Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1961 1
1966 2
1975 1
1977 1
1979 1
1982 1
1985 2
1986 1
1988 1
1989 2
1990 2
1993 2
1994 1
1995 1
1996 3
1997 1
1999 1
2000 6
2001 3
2002 1
2003 1
2004 1
2005 3
2006 1
2007 4
2008 1
2010 1
2013 2
2014 1
2015 2
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr; American Society of Clinical Oncology. Harris L, et al. Among authors: fritsche h. J Clin Oncol. 2007 Nov 20;25(33):5287-312. doi: 10.1200/JCO.2007.14.2364. Epub 2007 Oct 22. J Clin Oncol. 2007. PMID: 17954709 Review.
Translational crossroads for biomarkers.
Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A. Bast RC Jr, et al. Among authors: fritsche h. Clin Cancer Res. 2005 Sep 1;11(17):6103-8. doi: 10.1158/1078-0432.CCR-04-2213. Clin Cancer Res. 2005. PMID: 16144908 Free article. Review.
Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne.
Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M. Nison L, et al. Among authors: fritsche h. Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182. Prog Urol. 2015. PMID: 26544377 French. No abstract available.
Adnexal mass risk assessment: a multivariate index assay for malignancy risk stratification.
Zhang Z, Bullock RG, Fritsche H. Zhang Z, et al. Among authors: fritsche h. Future Oncol. 2019 Nov;15(33):3783-3795. doi: 10.2217/fon-2019-0479. Epub 2019 Oct 1. Future Oncol. 2019. PMID: 31570013 Free article.
Ethnic disparity in clinical performance between multivariate index assay and CA125 in detection of ovarian malignancy.
Dunton C, Bullock RG, Fritsche H. Dunton C, et al. Among authors: fritsche h. Future Oncol. 2019 Sep;15(26):3047-3051. doi: 10.2217/fon-2019-0310. Epub 2019 Aug 9. Future Oncol. 2019. PMID: 31397588 Free article.
Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women.
Dunton C, Bullock RG, Fritsche H. Dunton C, et al. Among authors: fritsche h. Biomark Cancer. 2019 Jun 14;11:1179299X19853785. doi: 10.1177/1179299X19853785. eCollection 2019. Biomark Cancer. 2019. PMID: 31236012 Free PMC article.
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.
Hayes DF, Bast RC, Desch CE, Fritsche H Jr, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG, Norton L, Ravdin P, Taube S, Winn RJ. Hayes DF, et al. Among authors: fritsche h jr. J Natl Cancer Inst. 1996 Oct 16;88(20):1456-66. doi: 10.1093/jnci/88.20.1456. J Natl Cancer Inst. 1996. PMID: 8841020 Review.
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.
Woo M, Przepiorka D, Ippoliti C, Warkentin D, Khouri I, Fritsche H, Körbling M. Woo M, et al. Among authors: fritsche h. Bone Marrow Transplant. 1997 Dec;20(12):1095-8. doi: 10.1038/sj.bmt.1701027. Bone Marrow Transplant. 1997. PMID: 9466284 Free article. Review.
TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.
Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell GM, Alp G, Schewe D, Hübner S, Tiwari S, Kownatzki D, Boretius S, Adam D, Jonat W, Becker T, Glüer CC, Zöller M, Kalthoff H, Schem C, Trauzold A. Fritsche H, et al. Oncotarget. 2015 Apr 20;6(11):9502-16. doi: 10.18632/oncotarget.3321. Oncotarget. 2015. PMID: 25909161 Free PMC article.
Physiological hypoxia promotes lipid raft and PI3K-dependent activation of MAPK 42/44 in leukemia cells.
Fiegl M, Samudio I, Mnjoyan Z, Korchin B, Fritsche H, Andreeff M. Fiegl M, et al. Among authors: fritsche h. Leukemia. 2010 Jul;24(7):1364-7. doi: 10.1038/leu.2010.94. Epub 2010 May 27. Leukemia. 2010. PMID: 20508615 Free PMC article. No abstract available.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback